Hereditary Cancer Testing Market: Global Growth & Trends

Hereditary Cancer Testing Market Size Was Valued at USD 7.3 Billion in 2023, and is Projected to Reach USD 14.9 Billion by 2032, Growing at a CAGR of 8.3% From 2024-2032.

Hereditary Cancer Testing Market can be defined as the healthcare industry’s niche involving the delivery of genetic tests that can help determine predisposition to certain types of cancer. These tests aid in establish genetic cancer susceptibility syndromes that run in families and increase the risk of getting cancers of Breast, Ovary, Colon, and Prostrate. Hereditary cancer testing is based on an inspection of a human organism’s DNA to identify certain inherited mutations of genes, chromosomes or proteins. The findings are useful to aid in early identification, delay or prevention, and target management plans.